Medtronic acquired the technology last July when it purchased Salient Surgical Technologies for $480 million. Medtronic had participated in Salient’s seven rounds of funding over the past 10 years. The surgical sealer uses “Transcollation” technology — a combination of radiofrequency energy and saline — and is designed for use with cut muscle tissue and with epidural veins.
Related Articles on Medical Devices:
MScore Technology Assesses Surgeon Competency With da Vinci Robot
FDA, Life Sciences Trade Group Partner to Improve Medical Device Review
Investment in Medical Device and Biotech Firms Hit 15-Year Low in 2011
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
